메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 30, Issue 25, 2012, Pages 3148-3149
Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR;
EID: 84865798486     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.4746     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 84858843113 scopus 로고    scopus 로고
    • Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer
    • Hershman DL, Wilde ET, Wright JD, et al: Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol 30:806-812, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 806-812
    • Hershman, D.L.1    Wilde, E.T.2    Wright, J.D.3
  • 2
    • 84858842797 scopus 로고    scopus 로고
    • Wiser use of dose-dense adjuvant therapy in breast cancer
    • Hilner BE, Smith TJ: Wiser use of dose-dense adjuvant therapy in breast cancer. J Clin Oncol 30:772-773, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 772-773
    • Hilner, B.E.1    Smith, T.J.2
  • 3
    • 78650384680 scopus 로고    scopus 로고
    • Dose-dense chemotherapy in nonmetastatic breast cancer: A systematic review and meta-analysis of randomized controlled trials
    • Bonilla L, Ben-Aharon I, Vidal L, et al: Dose-dense chemotherapy in nonmetastatic breast cancer: A systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst 102:1845-1854, 2010
    • (2010) J Natl Cancer Inst , vol.102 , pp. 1845-1854
    • Bonilla, L.1    Ben-Aharon, I.2    Vidal, L.3
  • 4
    • 84856636292 scopus 로고    scopus 로고
    • Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    • Early Breast Cancer Trialists' Collaborative Group E
    • Early Breast Cancer Trialists' Collaborative Group E: Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 379:432-444, 2012
    • (2012) Lancet , vol.379 , pp. 432-444
  • 5
    • 19344364880 scopus 로고    scopus 로고
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
    • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
    • (2005) Lancet , vol.365 , pp. 1687-1717
  • 6
    • 84867826426 scopus 로고    scopus 로고
    • NSABP B-38: Definitive analysis of a randomized trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer
    • abstr LBA1000
    • Swain SM, Tang G, Geyer CE Jr, et al: NSABP B-38: Definitive analysis of a randomized trial comparing dose-dense (DD) AC→paclitaxel (P) plus gemcitabine (G) with DD AC→P and with docetaxel, doxorubicin, and cyclophosphamide (TAC) in women with operable, node-positive breast cancer. J Clin Oncol 30:49s 2012 (abstr LBA1000)
    • (2012) J Clin Oncol , vol.30
    • Swain, S.M.1    Tang, G.2    Geyer Jr., C.E.3
  • 7
    • 33645729203 scopus 로고    scopus 로고
    • Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
    • Berry DA, Cirrincione C, Henderson IC, et al: Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer. JAMA 295:1658-1667, 2006
    • (2006) JAMA , vol.295 , pp. 1658-1667
    • Berry, D.A.1    Cirrincione, C.2    Henderson, I.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.